The data is most definitely not there for BTD. The average numbers for fat (25%) and fibrosis (8%) reduction are directional only. These are not fantastic by any measure.
Have a look at Madrigal's PH2 data for comparison. Leronlimab has not shown (yet) that it has the same or better performance.
Market Data 
Markets 
AI
